Call to Schedule Free Consultation at Over 80 Centers Worldwide!
Autoimmune
Cardiovascular
Endocrine
Liver
Musculoskeletal
Neurological
Other
Respiratory/Pulmonary
Reproductive
Renal/Kidney
Urologic
Autoimmune
Cardiovascular
Endocrine
Liver
Musculoskeletal
Neurological
Other
Respiratory/Pulmonary
Reproductive
Renal/Kidney
Urologic
Written by Dr. David Greene, MD, PhD, MBA on November 18, 2026

A new option for Floridians exploring regenerative care for joint, musculoskeletal, and pain conditions, offered under Florida’s 2025 stem cell therapy law
ORLANDO, Fla. — R3 Stem Cell is now offering MUSE cell therapy at its Orlando flagship location, bringing this newer category of regenerative cell therapy to Central Florida. The clinic is located at5844 Red Bug Lake Rd, Winter Springs, FL 32708.Treatments are performed by R3 USA Medical Director Dr. Geneva Worthington.
For patients living with painful joints, nagging tendon and ligament problems, or chronic musculoskeletal pain, the arrival of MUSE cells in Orlando means access to an emerging therapy without leaving the country. It also comes with something R3 believes every patient deserves: a clear, honest explanation of what MUSE cells are, what the science does and does not yet show, and how treatment works.
R3 Stem Cell is the ONLY USA clinics offering an FDA 361 Compliant MUSE stem cell procedure, meaning the therapy complies with both state and federal regulations!
MUSE stands for Multilineage-differentiating Stress Enduring cells. They were first identified in 2010 by Professor Mari Dezawa’s group at Tohoku University in Japan. MUSE cells are a small subpopulation of the cells found in connective tissues, including bone marrow, fat, and umbilical cord tissue, and they are identified by a surface marker called SSEA-3.
What makes them interesting to researchers is a combination of traits seen in laboratory and animal studies. MUSE cells appear to tolerate stress well, tend to migrate toward damaged tissue, and can develop into cell types from more than one tissue family. Unlike embryonic stem cells or lab-reprogrammed iPS cells, they have not been shown to form tumors in these studies. Those properties are why MUSE cells have become one of the more closely watched areas in regenerative medicine.
R3 Orlando uses NativeMUSE™, a MUSE cell product from Dux Bio derived from donated umbilical cord tissue (Wharton’s jelly). The tissue is collected after healthy, full-term births with the mother’s consent.
NativeMUSE™ is non-cultured, meaning the cells are not grown or expanded in a lab, and it is processed in an FDA-registered facility under federal human tissue regulations (21 CFR Part 1271). No embryonic or fetal tissue is used. The product is FDA compliant, offering patients the comfort knowing that it conforms to both state and federal regulations.
MUSE cell research is promising but still early. The most advanced human studies have taken place in Japan, using a clinical-grade MUSE cell product developed for research trials. Those trials have studied conditions such as subacute ischemic stroke, heart attack, spinal cord injury, ALS, and a rare blistering skin disease called epidermolysis bullosa. A randomized, placebo-controlled stroke trial published in 2023 reported encouraging safety and functional results, and its authors called for larger studies to confirm them.
Those trials used a different, laboratory-expanded product, studied different conditions, and were not conducted in Florida. Research specifically on MUSE cells for joints, cartilage, and musculoskeletal pain is largely preclinical so far. That is why R3 tracks patient outcomes over time and contributes to the broader research effort through its observational safety database.
R3 Stem Cell has the ONLY clinics in the world that have achieved IRB approval for an outcomes research study where patients are followed for a year to make sure the safety and outcomes are satisfactory.
At R3 Stem Cell’s Centers of Excellence, patients are evaluated with a free virtual consultation to see if they are a candidate. After 30,000 procedures in the past decade and an 85% patient satisfaction rate, R3 is the world’s largest and most successful regenerative clinics in the USA and globally.
During your consultation, our physician will review your history and imaging, talk through conventional treatment options you may not have tried yet, and give you an honest opinion about whether MUSE cell therapy makes sense for you. Sometimes the right answer is a different treatment, or no procedure at all.
In July 2025, Florida became one of the first states to allow physicians to offer stem cell therapies that have not been approved by the FDA, within defined limits. R3 Orlando follows each of those requirements:
Sourcing standards. Cells must come from a facility that is registered with the FDA and compliant with a recognized organization such as the American Association of Tissue Banks.
Proof of live cells. Each product lot must come with a post-thaw viability report confirming it contains live cells, and that report is in the physician’s hands before treatment.
Manufacturing quality. Products must come from facilities that follow current good manufacturing practices under federal tissue regulations.
Informed consent. Before any treatment, you will sign a consent form explaining what the treatment involves, that it is not FDA-approved, the results we expect, the known risks and benefits, and the alternatives, including no treatment. We also encourage you to talk with your primary care provider first.
Treatment begins with a consultation and review of your medical history and any imaging. If you and the physician decide to move forward, MUSE cell treatment is an outpatient procedure. Depending on the condition, cells are delivered by injection into the affected area, typically under ultrasound guidance for accuracy. R3 Stem Cell Orlando also offers intranasal MUSE stem cell therapy.
R3 Stem Cell operates more than 80 Centers of Excellence across multiple countries and has published 15 peer-reviewed research papers, including recent reviews on umbilical cord-derived cells in arthritis. The Orlando flagship brings that experience to Central Florida, along with the protections Florida law now provides. Revenue from R3’s paid treatments also helps fund the company’s free programs, including free treatment for veterans and ongoing research.
“MUSE stem cell therapy is extremely exciting, and R3 Orlando offers them with an FDA Compliant product. As the world’s largest providers of stem cell therapy, R3 focuses on patient satisfaction and safety paramount, with affordability as a cornerstone as well,” stated CEO David Greene, MD, PhD, MBA.
Schedule a consultation
To learn whether MUSE cell therapy may be right for you, call (844) GET-STEM to you’re your free virtual consultation with R3 Stem Cell Orlando.
THIS NOTICE MUST BE PROVIDED TO YOU UNDER FLORIDA LAW.
This physician performs one or more stem cell therapies that have not yet been approved by the United States Food and Drug Administration.
Contact Us